Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
BeOne Medicines registers Phase 1 trial of BG-T0050 in DLBCL and other B-cell cancersOct 21Weekly roundup, 5 itemsazacitidineBeiGene
Vanderbilt registers Phase 2 toripalimab trial in esophageal cancer, backed by CoherusSep 25Weekly roundup, 2 itemsadalimumab-aqvhadalimumab-atto
Coherus Oncology files to sell up to $50 million in stock through Leerink PartnersAug 28FinancingCoherus Oncology, Inc.
Coherus reports Q2 2026 results, flags October data update for tagmokitugAug 5Quarterly updateCoherus Oncology, Inc.toripalimab-tpzi